Ad is loading...
BEAM
Price
$26.71
Change
+$1.39 (+5.49%)
Updated
Dec 6 closing price
86 days until earnings call
KNSA
Price
$21.50
Change
+$0.52 (+2.48%)
Updated
Dec 6, 04:59 PM (EDT)
80 days until earnings call
Ad is loading...

BEAM vs KNSA

Header iconBEAM vs KNSA Comparison
Open Charts BEAM vs KNSABanner chart's image
Beam Therapeutics
Price$26.71
Change+$1.39 (+5.49%)
Volume$1.03M
CapitalizationN/A
Kiniksa Pharmaceuticals International
Price$21.50
Change+$0.52 (+2.48%)
Volume$3.85K
CapitalizationN/A
BEAM vs KNSA Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. KNSA commentary
Dec 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and KNSA is a Hold.

COMPARISON
Comparison
Dec 08, 2024
Stock price -- (BEAM: $26.71 vs. KNSA: $21.51)
Brand notoriety: BEAM and KNSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 96% vs. KNSA: 103%
Market capitalization -- BEAM: $2.1B vs. KNSA: $1.51B
BEAM [@Biotechnology] is valued at $2.1B. KNSA’s [@Biotechnology] market capitalization is $1.51B. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileKNSA’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • KNSA’s FA Score: 1 green, 4 red.
According to our system of comparison, KNSA is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while KNSA’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • KNSA’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, KNSA is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -2.41% price change this week, while KNSA (@Biotechnology) price change was -2.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

KNSA is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.1B) has a higher market cap than KNSA($1.52B). KNSA YTD gains are higher at: 22.634 vs. BEAM (-1.874). KNSA has higher annual earnings (EBITDA): -24.4M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. KNSA (224M). KNSA has less debt than BEAM: KNSA (10.6M) vs BEAM (162M). KNSA has higher revenues than BEAM: KNSA (384M) vs BEAM (350M).
BEAMKNSABEAM / KNSA
Capitalization2.1B1.52B138%
EBITDA-160.83M-24.4M659%
Gain YTD-1.87422.634-8%
P/E RatioN/A164.54-
Revenue350M384M91%
Total Cash926M224M413%
Total Debt162M10.6M1,528%
FUNDAMENTALS RATINGS
KNSA: Fundamental Ratings
KNSA
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
42
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMKNSA
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 18 days ago
86%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
89%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NGDCX29.660.20
+0.68%
Neuberger Berman Large Cap Growth C
CGCIX14.230.01
+0.07%
Calamos Global Opportunities I
DILRX16.89N/A
N/A
DFA International Large Cap Growth
AUERX17.35-0.20
-1.14%
Auer Growth
FZANX45.74-1.99
-4.17%
Fidelity Advisor New Insights Z

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with ABVC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then ABVC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+2.53%
ABVC - KNSA
40%
Loosely correlated
-5.66%
NTLA - KNSA
38%
Loosely correlated
+7.84%
FATE - KNSA
38%
Loosely correlated
+11.34%
AMRN - KNSA
36%
Loosely correlated
-1.77%
BEAM - KNSA
35%
Loosely correlated
+5.49%
More